Related Experiment Video
Updated: Feb 9, 2026

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
Pitfall of 18F-FDG PET/CT in Characterization of Relapsed Multisystem Lymphomatoid Granulomatosis
Kelly Tung1, Allison C Rosenthal2, Fiona E Craig3
1Department of Radiology, Mayo Clinic Arizona, Scottsdale, Arizona.
Abstract:
We present serial 18F-FDG PET/CT findings in a case of grade 3 pulmonary lymphomatoid granulomatosis positive for the Epstein-Barr virus. The patient experienced a transient complete response to R-CHOP chemotherapy and subsequent multisystem recurrence, predominately involving the subcutaneous region of the torso on 18F-FDG PET/CT. Biopsy of the most hypermetabolic subcutaneous lesion demonstrated grade 1 cutaneous lymphomatoid granulomatosis negative for the Epstein-Barr virus. This report highlights the role of 18F-FDG PET/CT in characterizing and monitoring disease progression and regression, as well as the limitations of 18F-FDG PET/CT in accurate grading of multisystem recurrence, given the diversity of clinical and histopathologic features of lymphomatoid granulomatosis.
Insights
Serial 18F-FDG PET/CT imaging revealed transient response and multisystem recurrence of pulmonary lymphomatoid granulomatosis. Recurrence grading was limited by diverse histopathology despite imaging findings.
Area of Science:
- Oncology
- Nuclear Medicine
- Pathology
Background:
- Lymphomatoid granulomatosis (LYG) is a rare lymphoproliferative disorder.
- Pulmonary involvement is common, and Epstein-Barr virus (EBV) positivity is associated with poorer prognosis.
- Accurate staging and monitoring are crucial for treatment planning.
Observation:
- A case of EBV-positive, grade 3 pulmonary LYG treated with R-CHOP chemotherapy is presented.
- Serial 18F-FDG PET/CT demonstrated an initial complete response followed by multisystem recurrence, predominantly in the subcutaneous torso.
- Biopsy of subcutaneous lesions revealed EBV-negative, grade 1 cutaneous LYG.
Findings:
- 18F-FDG PET/CT effectively monitored treatment response and identified disease recurrence.
- Discordance between PET/CT findings and histopathology in recurrence grading was observed.
- EBV status changed from positive in pulmonary LYG to negative in cutaneous recurrence.
Implications:
- 18F-FDG PET/CT is valuable for assessing LYG treatment response and detecting recurrence.
- Limitations exist in differentiating LYG grades and subtypes based solely on 18F-FDG PET/CT.
- The heterogeneity of LYG necessitates integrated clinical, imaging, and histopathological evaluation.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Aggression

